Literature DB >> 18723674

Lack of adrenomedullin in the mouse brain results in behavioral changes, anxiety, and lower survival under stress conditions.

Ana P Fernández1, Julia Serrano, Lino Tessarollo, Frank Cuttitta, Alfredo Martínez.   

Abstract

The adrenomedullin (AM) gene, adm, is widely expressed in the central nervous system (CNS) and several functions have been suggested for brain AM. Until now, a formal confirmation of these actions using genetic models has been elusive since the systemic adm knockout results in embryo lethality. We have built a conditional knockout mouse model using the Cre/loxP approach. When crossed with transgenic mice expressing the Cre recombinase under the tubulin Talpha-1 promoter, we obtained animals with no AM expression in the CNS but normal levels in other organs. These animals lead normal lives and do not present any gross morphological defect. Specific areas of the brain of animals lacking CNS AM contain hyperpolymerized tubulin, a consequence of AM downregulation. Behavioral analysis shows that mice with no AM in their brain have impaired motor coordination and are hyperactive and overanxious when compared to their wild-type littermates. Treatment with methylphenidate, haloperidol, and diazepam did not show differences between genotypes. Circulating levels of adrenocorticotropic hormone and corticosterone were similar in knockout and wild-type mice. Animals with no brain AM were less resistant to hypobaric hypoxia than wild-type mice, demonstrating the neuroprotective function of AM in the CNS. In conclusion, AM exerts a beneficial action in the brain by maintaining homeostasis both under normal and stress conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18723674      PMCID: PMC2527954          DOI: 10.1073/pnas.0803174105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Distribution of preproadrenomedullin mRNA in the rat central nervous system and its modulation by physiological stressors.

Authors:  J Shan; T L Krukoff
Journal:  J Comp Neurol       Date:  2001-03-26       Impact factor: 3.215

Review 2.  Isolation, microinjection, and transfer of mouse blastocysts.

Authors:  A Bonin; S W Reid; L Tessarollo
Journal:  Methods Mol Biol       Date:  2001

3.  Distribution of adrenomedullin-like immunoreactivity in the rat central nervous system by light and electron microscopy.

Authors:  J Serrano; L O Uttenthal; A Martínez; A P Fernández; J Martínez de Velasco; D Alonso; M L Bentura; M Santacana; J R Gallardo; R Martínez-Murillo; F Cuttitta; J Rodrigo
Journal:  Brain Res       Date:  2000-01-24       Impact factor: 3.252

4.  Noncompensation in peptide/receptor gene expression and distinct behavioral phenotypes in VIP- and PACAP-deficient mice.

Authors:  Beatrice A Girard; Vincent Lelievre; Karen M Braas; Tannaz Razinia; Margaret A Vizzard; Yevgeniya Ioffe; Rajaa El Meskini; Gabriele V Ronnett; James A Waschek; Victor May
Journal:  J Neurochem       Date:  2006-10       Impact factor: 5.372

5.  Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity.

Authors:  M Rios; G Fan; C Fekete; J Kelly; B Bates; R Kuehn; R M Lechan; R Jaenisch
Journal:  Mol Endocrinol       Date:  2001-10

6.  Expression of receptor-activity modifying protein (RAMP) mRNAs in the mouse brain.

Authors:  T Ueda; S Ugawa; Y Saishin; S Shimada
Journal:  Brain Res Mol Brain Res       Date:  2001-09-10

7.  Adrenomedullin expression is up-regulated by ischemia-reperfusion in the cerebral cortex of the adult rat.

Authors:  J Serrano; D Alonso; J M Encinas; J C Lopez; A P Fernandez; S Castro-Blanco; P Fernández-Vizarra; A Richart; M L Bentura; M Santacana; L O Uttenthal; F Cuttitta; J Rodrigo; A Martinez
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

8.  Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage.

Authors:  Tatsuo Shimosawa; Yugo Shibagaki; Kotaro Ishibashi; Kazuo Kitamura; Kenji Kangawa; Shigeaki Kato; Katsuyuki Ando; Toshiro Fujita
Journal:  Circulation       Date:  2002-01-01       Impact factor: 29.690

9.  Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene.

Authors:  T Shindo; Y Kurihara; H Nishimatsu; N Moriyama; M Kakoki; Y Wang; Y Imai; A Ebihara; T Kuwaki; K H Ju; N Minamino; K Kangawa; T Ishikawa; M Fukuda; Y Akimoto; H Kawakami; T Imai; H Morita; Y Yazaki; R Nagai; Y Hirata; H Kurihara
Journal:  Circulation       Date:  2001-10-16       Impact factor: 29.690

10.  Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional Adrenomedullin gene.

Authors:  K M Caron; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-09       Impact factor: 11.205

View more
  28 in total

1.  Upregulation of transcription factor NRF2-mediated oxidative stress response pathway in rat brain under short-term chronic hypobaric hypoxia.

Authors:  Niroj Kumar Sethy; Manjulata Singh; Rajesh Kumar; Govindasamy Ilavazhagan; Kalpana Bhargava
Journal:  Funct Integr Genomics       Date:  2010-10-05       Impact factor: 3.410

Review 2.  Brainstem neuropeptides and vagal protection of the gastric mucosal against injury: role of prostaglandins, nitric oxide and calcitonin-gene related peptide in capsaicin afferents.

Authors:  Y Tache
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

3.  Glu-tubulin is a marker for Schwann cells and can distinguish between schwannomas and neurofibromas.

Authors:  Josune García-Sanmartín; Susana Rubio-Mediavilla; José J Sola-Gallego; Alfredo Martínez
Journal:  Histochem Cell Biol       Date:  2016-06-09       Impact factor: 4.304

4.  The neuronal oxygen-sensing pathway controls postnatal vascularization of the murine brain.

Authors:  Emil Nasyrov; Karen A Nolan; Roland H Wenger; Hugo H Marti; Reiner Kunze
Journal:  FASEB J       Date:  2019-08-30       Impact factor: 5.191

Review 5.  Adrenomedullin 2/intermedin in the hypothalamo-pituitary-adrenal axis.

Authors:  Kazuhiro Takahashi; Ryo Morimoto; Takuo Hirose; Fumitoshi Satoh; Kazuhito Totsune
Journal:  J Mol Neurosci       Date:  2010-07-02       Impact factor: 3.444

6.  Shear stress-induced endothelial adrenomedullin signaling regulates vascular tone and blood pressure.

Authors:  Andras Iring; Young-June Jin; Julián Albarrán-Juárez; Mauro Siragusa; ShengPeng Wang; Péter T Dancs; Akiko Nakayama; Sarah Tonack; Min Chen; Carsten Künne; Anna M Sokol; Stefan Günther; Alfredo Martínez; Ingrid Fleming; Nina Wettschureck; Johannes Graumann; Lee S Weinstein; Stefan Offermanns
Journal:  J Clin Invest       Date:  2019-06-17       Impact factor: 14.808

7.  Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression.

Authors:  Jie Huang; Roy H Perlis; Phil H Lee; A John Rush; Maurizio Fava; Gary S Sachs; Jeffrey Lieberman; Steven P Hamilton; Patrick Sullivan; Pamela Sklar; Shaun Purcell; Jordan W Smoller
Journal:  Am J Psychiatry       Date:  2010-08-16       Impact factor: 18.112

8.  Genome-wide identification of new Wnt/beta-catenin target genes in the human genome using CART method.

Authors:  Christian Hödar; Rodrigo Assar; Marcela Colombres; Andrés Aravena; Leonardo Pavez; Mauricio González; Servet Martínez; Nibaldo C Inestrosa; Alejandro Maass
Journal:  BMC Genomics       Date:  2010-06-01       Impact factor: 3.969

Review 9.  Adrenomedullin, a Novel Target for Neurodegenerative Diseases.

Authors:  Hilda Ferrero; Ignacio M Larrayoz; Francisco J Gil-Bea; Alfredo Martínez; María J Ramírez
Journal:  Mol Neurobiol       Date:  2018-03-29       Impact factor: 5.590

10.  Multiple organ system defects and transcriptional dysregulation in the Nipbl(+/-) mouse, a model of Cornelia de Lange Syndrome.

Authors:  Shimako Kawauchi; Anne L Calof; Rosaysela Santos; Martha E Lopez-Burks; Clint M Young; Michelle P Hoang; Abigail Chua; Taotao Lao; Mark S Lechner; Jeremy A Daniel; Andre Nussenzweig; Leonard Kitzes; Kyoko Yokomori; Benedikt Hallgrimsson; Arthur D Lander
Journal:  PLoS Genet       Date:  2009-09-18       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.